FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 104 filers reported holding FATE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,000 | +33.3% | 800 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -15.8% | 800 | -27.3% | 0.00% | – |
| Q1 2019 | $19,000 | +35.7% | 1,100 | 0.0% | 0.00% | – |
| Q4 2018 | $14,000 | -41.7% | 1,100 | -27.4% | 0.00% | – |
| Q3 2018 | $24,000 | +33.3% | 1,515 | -5.3% | 0.00% | – |
| Q2 2018 | $18,000 | +12.5% | 1,600 | 0.0% | 0.00% | – |
| Q1 2018 | $16,000 | +14.3% | 1,600 | -30.4% | 0.00% | – |
| Q4 2017 | $14,000 | +55.6% | 2,300 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +12.5% | 2,300 | -11.5% | 0.00% | – |
| Q2 2017 | $8,000 | -11.1% | 2,600 | +30.0% | 0.00% | – |
| Q1 2017 | $9,000 | +80.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |